10-K/A: BIO-key International Files Amended 10-K to Correct Auditor's Report Date

BIO-key International has filed an amendment to its annual report to correct a typographical error in the date of the auditor's report, with no other changes to the financial statements.

Summary

• BIO-key International filed an amendment to its 10-K report to correct a typographical error in the date of the auditor's report from June 5, 2024 to June 1, 2023.
• The amendment includes updated certifications from the CEO and CFO as required by the Sarbanes-Oxley Act.
• The company's financial statements for the year ended December 31, 2023, show a net loss of $8,521,837, compared to a net loss of $11,909,903 in 2022.
• Total revenue for 2023 was $7,754,905, an increase from $7,020,258 in 2022.
• The company's cash and cash equivalents decreased significantly from $2,635,522 in 2022 to $511,400 in 2023.
• The company has a history of net losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern.
• A 1-for-18 reverse stock split was implemented on December 21, 2023, and all share data has been adjusted retrospectively.
• The company's accumulated deficit increased to $125,007,210 by the end of 2023.

Sentiment

Score: 3

Explanation: The document highlights significant financial challenges, including substantial losses, negative cash flow, and a going concern warning from auditors. While there was a slight improvement in net loss, the overall financial health of the company is weak.

Positives

• The company's net loss decreased from $11,909,903 in 2022 to $8,521,837 in 2023.
• Total revenue increased from $7,020,258 in 2022 to $7,754,905 in 2023.

Negatives

• The company's cash and cash equivalents decreased significantly from $2,635,522 in 2022 to $511,400 in 2023.
• The company has a history of substantial net losses and negative cash flows from operations.
• The company is dependent on debt and equity financing to fund its operations.
• Auditors have expressed substantial doubt about the company's ability to continue as a going concern.
• The company's accumulated deficit increased to $125,007,210 by the end of 2023.

Risks

• The company's ability to continue as a going concern is in doubt due to substantial net losses and negative cash flows.
• The company is heavily reliant on debt and equity financing to fund operations.
• The company's cash reserves have significantly decreased.
• The company has a large accumulated deficit.
• The company's inventory has been reserved due to slow moving goods purchased for projects in Nigeria.

Future Outlook

The company's future is uncertain due to its financial condition and dependence on external financing. Management is exploring options to generate additional cash, including selling or returning inventory.

Management Comments

• Management has lowered expenses through decreasing spending in marketing, and research and development.
• Management is looking into other markets and opportunities to sell or return the product to generate additional cash.

Industry Context

The company operates in the competitive biometric technology and identity access management sector. The financial results indicate challenges in achieving profitability and maintaining sufficient cash reserves, which could impact its ability to compete effectively.

Comparison to Industry Standards

• The company's financial performance, particularly the recurring losses and negative cash flow, is concerning when compared to industry standards for established technology companies.
• Many competitors in the biometric and identity management space have achieved profitability and have stronger balance sheets.
• The company's reliance on external financing is higher than many of its peers, indicating a weaker financial position.
• The company's negative cash flow from operations is a significant concern, as many successful technology companies generate positive cash flow.

Related Party Transactions

• A member of the company's board of directors served as Chief Executive Officer of TTI until August 12, 2020, which is a company that BIO-key has a note receivable from.

Stakeholder Impact

• Shareholders face significant risk due to the company's financial instability and going concern issues.
• Employees may be concerned about job security given the company's financial challenges.
• Customers and suppliers may be wary of the company's ability to fulfill contracts and obligations.

Next Steps

• The company is exploring options to sell or return inventory to generate additional cash.
• The company is working to remediate a material weakness in internal controls over the recording and processing of revenues, allowances for accounts receivable and certain reserves for inventory.

Key Dates

Keywords

financial statements, biometric technology, reverse stock split, going concern, net loss, revenue, cash flow, auditor's report, debt financing, equity financing